What's New at The Body
HIV/AIDS News You Can Use
September 5, 2001
September Visual AIDS GalleryThe September Visual AIDS Web Gallery is now live! This month's gallery features the work of archive members Garrett Brock, Milton Garcia Latex, Rebecca Guberman, Carlos Gutierrez-Solana, Chet Holcomb, Barry Huff, Melvin Jay, Ronald Bruce Monroe, Joe Monroe, Michael Moore, John Morrison, Luna Luis Ortiz, Nelson Rodriguez, Jorge Veras and Laurence Young. Click here to view the gallery!
Day to Day with HIV"There's a sore on the back of my tongue . . . I smoke too many Marlboros, so it could be cancer. I engage in unprotected oral sex on occasion, so it could be gonorrhea. I am HIV-positive and take Viramune, so it could be a side effect of my newest medication." John Kirby writes about life with HIV, in Positive Living.
U.S. HIV Prevention Policy"With 300,000 people in the U.S. who are not aware that they are living with HIV, it is evident that there is an urgent need for more accessible HIV counseling and testing." The facts about HIV prevention, from AIDS Action.
AIDS Doctors"AIDS Doctors" is the story, in their own words, of physicians who chose to care for patients with AIDS. Read an excerpt of this fascinating book, from Body Positive.
President Bush and AIDS"George W. hasn't a clue about AIDS. First he planned to close the White House Office of National AIDS Policy . . . then he appointed someone who, though gay, has no experience in HIV treatment or prevention and no policymaking background." David Sayler writes frankly about AIDS policy in the United States.
New Treatment Activist CoalitionTwenty-one U.S. AIDS treatment activists met for three days in August to outline a new coalition they are calling AIDS Treatment Activist Coalition. Their goal: to improve AIDS research, treatment access, and empowerment of new activists in communities most affected by the epidemic. Click here for the details from AIDS Treatment News.
Tenofovir Public HearingOn October 3rd the FDA's Antiviral Drugs Advisory Committee will hold a public hearing on tenofovir, an antiretroviral developed by Gilead Sciences and currently in pre-approval expanded access.
AIDS Treatment News RoundupsCheck out this roundup of treatment news from AIDS Survival Project.
HIV treatment news roundup, from Houston's Center for AIDS.
Treatment Conference ReportDawn Averitt summarizes highlights from the recent International AIDS Society Conference.
More on Immune-Based TherapyImmune-based therapy is the next frontier in AIDS treatment. Recent studies have shown that manipulation of the immune system to control HIV is possible. David Pieribone explores why this new therapy is so important, in Positive Living.
Organ TransplantsNow that many HMOs are covering organ transplants for people with HIV, check out The Body's new section on transplants.
Personal AdsVisit The Body's BBS and connect with others!
Update on Viatical SettlementsAre viatical settlements still an option? AIDS Survival Project takes a look at the details on selling your life insurance.
Health Risks for Homeless TeensThe health risk behaviors of homeless teens are, as you may imagine, a long list. Read the details from SIECUS.
Correct Condom Use for TeensIt's been confirmed -- many sexuality and HIV/STD education programs provided to adolescents, particularly school-based programs, do not adequately address correct condom-use procedures. Read the details from SIECUS.
Comprehensive NYC HIV ResourceNeed an HIV/AIDS resource in New York City? Check out the Body Positive HIV/AIDS Resource Directory now in PDF format on our site!
Protease Inhibitors Reduce Liver Damage?A study to see if protease inhibitors increased the risk of liver toxicity in persons coinfected with hepatitis C unexpectedly found that protease inhibitors may reduce liver damage. Click here to read more from AIDS Treatment News.
Homocysteine and Cardiovascular RiskToo much homocysteine in the blood is associated with an increased risk of heart and circulatory diseases. Blood tests can detect the problem, and it can often be treated with nutrition and supplements. Here is some background from AIDS Treatment News on this potential approach to reducing cardiovascular risk.
Ribavirin for Hepatitis CFDA approved a stand-alone package of ribavirin for combination therapy with Intron A for the treatment of chronic hepatitis C infection. Click here for the details.
2 Decades Later, No AIDS Vaccine